A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g

A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis

NCT00287118 ·Status: COMPLETED ·Phase: PHASE4

Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy

NCT00368654 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

NCT00115076 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

NCT00096928 ·Status: COMPLETED

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

NCT00302445 ·Status: COMPLETED ·Phase: PHASE4

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

NCT01543204 ·Status: TERMINATED ·Phase: PHASE4

RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

NCT00402818 ·Status: TERMINATED

TRUST Study: Raptiva ® in Hand & Foot Psoriasis

NCT00739882 ·Status: TERMINATED ·Phase: PHASE4

Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)

NCT00602823 ·Status: COMPLETED

MAP Study: Methotrexate and Adalimumab in Psoriasis

NCT03217734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

NCT00312026 ·Status: COMPLETED ·Phase: PHASE4

ChangE From Any Systemic psoriasiS therapY to Raptiva

NCT00697593 ·Status: TERMINATED ·Phase: PHASE4

ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT01208090 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

NCT05701995 ·Status: COMPLETED ·Phase: PHASE4

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT03410992 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis

NCT00396422 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp

NCT00669214 ·Status: COMPLETED ·Phase: PHASE4

A Study of LY3361237 in Participants With Psoriasis

NCT04975295 ·Status: COMPLETED ·Phase: PHASE1

CLEAR Study: Clinical Experience Acquired With Raptiva Study

NCT00256139 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

NCT00097240 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)

NCT01729754 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

NCT02016482 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

NCT00338143 ·Status: COMPLETED ·Phase: PHASE3

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

NCT01877668 ·Status: COMPLETED ·Phase: PHASE3